Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Genomics & Health Impact Scan Database|Search|PHGKB

Cancer

Last data update: Mar 21, 2023. (Total: 58828 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 91 Records)

Next

Query Trace: Breast Cancer[original query]>>Guidelines Related[Product Type]
EBCC-13 manifesto: Balancing pros and cons for contralateral prophylactic mastectomy.
Schmidt Marjanka K et al. European journal of cancer (Oxford, England : 1990) 2023 18179-91
Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer.
Abdel-Razeq Hikmat et al. Breast cancer (Dove Medical Press) 2023 151-10
Updated ASCO guidelines for patients with HER2-positive breast cancer.
et al. Cancer 2022 129(1) 10
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2.
Hanson Helen et al. Journal of medical genetics 2022
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology.
Miglietta Federica et al. Breast (Edinburgh, Scotland) 2022 66293-304
Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.
Matan Liat S et al. European journal of obstetrics, gynecology, and reproductive biology 2022 278166-171
Overview of the Clinical Features of Li-Fraumeni Syndrome and the Current European ERN GENTURIS Guideline.
Kratz Christian Peter et al. Geburtshilfe und Frauenheilkunde 2022 82(1) 42-49
Practical Consensus Recommendations for Optimizing Risk versus Benefit of Chemotherapy in Patients with HR Positive Her2 Negative Early Breast Cancer in India.
Parikh Purvish M et al. South Asian journal of cancer 2022 10(4) 213-219
Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
Kumamoto Tadashi et al. International journal of clinical oncology 2021
Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe.
Marmolejo David Humberto et al. European journal of medical genetics 2021 104350
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Tischkowitz Marc et al. Genetics in medicine : official journal of the American College of Medical Genetics 2021
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative.
Giorgi Rossi Paolo et al. British journal of cancer 2021 Feb
Update: variable implementation of the 2018 UKCGG/UKGTN guidelines for breast cancer gene panel tests offered by UK genetics services.
Wedderburn Sarah et al. Journal of medical genetics 2021 Feb
Hereditary diffuse gastric cancer: updated clinical practice guidelines.
Blair Vanessa R et al. The Lancet. Oncology 2020 Aug 21(8) e386-e397
Genetic Testing and Screening Recommendations for Patients with Hereditary Breast Cancer.
Bharucha Puja P et al. Radiographics : a review publication of the Radiological Society of North America, Inc 2020 May 190181
ASTRO Radiation Therapy Summary of the ASCO-ASTRO-SSO Guideline on Management of Hereditary Breast Cancer.
Trombetta Mark G et al. Practical radiation oncology 2020 May
2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina.
Bešlija Semir et al. Bosnian journal of basic medical sciences 2020 May
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.
Tung Nadine M et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Apr JCO2000299
Management of Hereditary Breast Cancer
ASCO, April 3, 2020
[Latest international guidelines for screening, prevention and treatment of familial breast cancer - implications for the relevant practice in Hungary].
Romics László et al. Orvosi hetilap 2016 Jul 157(28) 1117-25
Management of Male Breast Cancer: ASCO Guideline.
Hassett Michael J et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Feb JCO1903120
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG).
Pal Tuya et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Dec
Position Statement on Direct to Consumer Genetic Testing
Royal College of General Practitioners, November 2019
Breast Cancer Chemoprevention: A Practical Guide for the Primary Care Provider.
Farkas Amy et al. Journal of women's health (2002) 2019 Sep
Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
, et al. JAMA 2019 0 0. (9) 857-867
US Preventive Services Task Force Breast Cancer Recommendation Statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.
Newman Lisa et al. JAMA surgery 2019 Aug
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
, et al. JAMA 2019 0 0. (7) 652-665
Local Coverage Determination (LCD): CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing (L35698)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): BRCA1 and BRCA2 Genetic Testing (L36715)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): BRCA1 and BRCA2 Genetic Testing (L36499)
The U.S. Centers for Medicare & Medicaid Services
TOP